GLOBAL DIGITAL COMPANION DIAGNOSTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Jul 2022 101
Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Digital Companion Diagnostics
1.2 Classification of Digital Companion Diagnostics by Type
1.2.1 Overview: Global Digital Companion Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Digital Companion Diagnostics Revenue Market Share by Type in 2021
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Next Generation Sequencing (NGS)
1.3 Global Digital Companion Diagnostics Market by Application
1.3.1 Overview: Global Digital Companion Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Global Digital Companion Diagnostics Market Size & Forecast
1.5 Global Digital Companion Diagnostics Market Size and Forecast by Region
1.5.1 Global Digital Companion Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Digital Companion Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Digital Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Digital Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Digital Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Digital Companion Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Digital Companion Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Digital Companion Diagnostics Market Drivers
1.6.2 Digital Companion Diagnostics Market Restraints
1.6.3 Digital Companion Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche Holdings (Switzerland)
2.1.1 Roche Holdings (Switzerland) Details
2.1.2 Roche Holdings (Switzerland) Major Business
2.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Product and Solutions
2.1.4 Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Holdings (Switzerland) Recent Developments and Future Plans
2.2 Abbott Laboratories (US)
2.2.1 Abbott Laboratories (US) Details
2.2.2 Abbott Laboratories (US) Major Business
2.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Product and Solutions
2.2.4 Abbott Laboratories (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Laboratories (US) Recent Developments and Future Plans
2.3 Thermo Fisher Scientific (US)
2.3.1 Thermo Fisher Scientific (US) Details
2.3.2 Thermo Fisher Scientific (US) Major Business
2.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.4 Agilent Technologies (US)
2.4.1 Agilent Technologies (US) Details
2.4.2 Agilent Technologies (US) Major Business
2.4.3 Agilent Technologies (US) Digital Companion Diagnostics Product and Solutions
2.4.4 Agilent Technologies (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Agilent Technologies (US) Recent Developments and Future Plans
2.5 Life Technologies (US)
2.5.1 Life Technologies (US) Details
2.5.2 Life Technologies (US) Major Business
2.5.3 Life Technologies (US) Digital Companion Diagnostics Product and Solutions
2.5.4 Life Technologies (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Life Technologies (US) Recent Developments and Future Plans
2.6 GE Healthcare (UK)
2.6.1 GE Healthcare (UK) Details
2.6.2 GE Healthcare (UK) Major Business
2.6.3 GE Healthcare (UK) Digital Companion Diagnostics Product and Solutions
2.6.4 GE Healthcare (UK) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GE Healthcare (UK) Recent Developments and Future Plans
2.7 Agendia (Angola)
2.7.1 Agendia (Angola) Details
2.7.2 Agendia (Angola) Major Business
2.7.3 Agendia (Angola) Digital Companion Diagnostics Product and Solutions
2.7.4 Agendia (Angola) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Agendia (Angola) Recent Developments and Future Plans
2.8 Qiagen (Germany)
2.8.1 Qiagen (Germany) Details
2.8.2 Qiagen (Germany) Major Business
2.8.3 Qiagen (Germany) Digital Companion Diagnostics Product and Solutions
2.8.4 Qiagen (Germany) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Qiagen (Germany) Recent Developments and Future Plans
2.9 Genomic Health (US)
2.9.1 Genomic Health (US) Details
2.9.2 Genomic Health (US) Major Business
2.9.3 Genomic Health (US) Digital Companion Diagnostics Product and Solutions
2.9.4 Genomic Health (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Genomic Health (US) Recent Developments and Future Plans
2.10 Myriad Genetics (US)
2.10.1 Myriad Genetics (US) Details
2.10.2 Myriad Genetics (US) Major Business
2.10.3 Myriad Genetics (US) Digital Companion Diagnostics Product and Solutions
2.10.4 Myriad Genetics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Myriad Genetics (US) Recent Developments and Future Plans
2.11 Advanced Cell Diagnostics (US)
2.11.1 Advanced Cell Diagnostics (US) Details
2.11.2 Advanced Cell Diagnostics (US) Major Business
2.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product and Solutions
2.11.4 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Advanced Cell Diagnostics (US) Recent Developments and Future Plans
2.12 Danaher (US)
2.12.1 Danaher (US) Details
2.12.2 Danaher (US) Major Business
2.12.3 Danaher (US) Digital Companion Diagnostics Product and Solutions
2.12.4 Danaher (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Danaher (US) Recent Developments and Future Plans
2.13 Applied Proteomics (US)
2.13.1 Applied Proteomics (US) Details
2.13.2 Applied Proteomics (US) Major Business
2.13.3 Applied Proteomics (US) Digital Companion Diagnostics Product and Solutions
2.13.4 Applied Proteomics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Applied Proteomics (US) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Digital Companion Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Digital Companion Diagnostics Players Market Share in 2021
3.2.2 Top 10 Digital Companion Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Digital Companion Diagnostics Players Head Office, Products and Services Provided
3.4 Digital Companion Diagnostics Mergers & Acquisitions
3.5 Digital Companion Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Digital Companion Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Digital Companion Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Digital Companion Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Digital Companion Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Digital Companion Diagnostics Revenue by Type (2017-2028)
6.2 North America Digital Companion Diagnostics Revenue by Application (2017-2028)
6.3 North America Digital Companion Diagnostics Market Size by Country
6.3.1 North America Digital Companion Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Digital Companion Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Digital Companion Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Digital Companion Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Digital Companion Diagnostics Revenue by Type (2017-2028)
7.2 Europe Digital Companion Diagnostics Revenue by Application (2017-2028)
7.3 Europe Digital Companion Diagnostics Market Size by Country
7.3.1 Europe Digital Companion Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Digital Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Digital Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Digital Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Digital Companion Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Digital Companion Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Digital Companion Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Region
8.3.1 Asia-Pacific Digital Companion Diagnostics Revenue by Region (2017-2028)
8.3.2 China Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Digital Companion Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Digital Companion Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Digital Companion Diagnostics Revenue by Type (2017-2028)
9.2 South America Digital Companion Diagnostics Revenue by Application (2017-2028)
9.3 South America Digital Companion Diagnostics Market Size by Country
9.3.1 South America Digital Companion Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Digital Companion Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Digital Companion Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Digital Companion Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Digital Companion Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Country
10.3.1 Middle East & Africa Digital Companion Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Digital Companion Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Digital Companion Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Digital Companion Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Digital Companion Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Digital Companion Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Digital Companion Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Digital Companion Diagnostics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Digital Companion Diagnostics Revenue Market Share by Region (2023-2028)
Table 6. Roche Holdings (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 7. Roche Holdings (Switzerland) Major Business
Table 8. Roche Holdings (Switzerland) Digital Companion Diagnostics Product and Solutions
Table 9. Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Laboratories (US) Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories (US) Major Business
Table 12. Abbott Laboratories (US) Digital Companion Diagnostics Product and Solutions
Table 13. Abbott Laboratories (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Thermo Fisher Scientific (US) Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific (US) Major Business
Table 16. Thermo Fisher Scientific (US) Digital Companion Diagnostics Product and Solutions
Table 17. Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Agilent Technologies (US) Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies (US) Major Business
Table 20. Agilent Technologies (US) Digital Companion Diagnostics Product and Solutions
Table 21. Agilent Technologies (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Life Technologies (US) Corporate Information, Head Office, and Major Competitors
Table 23. Life Technologies (US) Major Business
Table 24. Life Technologies (US) Digital Companion Diagnostics Product and Solutions
Table 25. Life Technologies (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GE Healthcare (UK) Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare (UK) Major Business
Table 28. GE Healthcare (UK) Digital Companion Diagnostics Product and Solutions
Table 29. GE Healthcare (UK) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Agendia (Angola) Corporate Information, Head Office, and Major Competitors
Table 31. Agendia (Angola) Major Business
Table 32. Agendia (Angola) Digital Companion Diagnostics Product and Solutions
Table 33. Agendia (Angola) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Qiagen (Germany) Corporate Information, Head Office, and Major Competitors
Table 35. Qiagen (Germany) Major Business
Table 36. Qiagen (Germany) Digital Companion Diagnostics Product and Solutions
Table 37. Qiagen (Germany) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Genomic Health (US) Corporate Information, Head Office, and Major Competitors
Table 39. Genomic Health (US) Major Business
Table 40. Genomic Health (US) Digital Companion Diagnostics Product and Solutions
Table 41. Genomic Health (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Myriad Genetics (US) Corporate Information, Head Office, and Major Competitors
Table 43. Myriad Genetics (US) Major Business
Table 44. Myriad Genetics (US) Digital Companion Diagnostics Product and Solutions
Table 45. Myriad Genetics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Advanced Cell Diagnostics (US) Corporate Information, Head Office, and Major Competitors
Table 47. Advanced Cell Diagnostics (US) Major Business
Table 48. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product and Solutions
Table 49. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Danaher (US) Corporate Information, Head Office, and Major Competitors
Table 51. Danaher (US) Major Business
Table 52. Danaher (US) Digital Companion Diagnostics Product and Solutions
Table 53. Danaher (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Applied Proteomics (US) Corporate Information, Head Office, and Major Competitors
Table 55. Applied Proteomics (US) Major Business
Table 56. Applied Proteomics (US) Digital Companion Diagnostics Product and Solutions
Table 57. Applied Proteomics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Digital Companion Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Digital Companion Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Digital Companion Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Digital Companion Diagnostics Players Head Office, Products and Services Provided
Table 62. Digital Companion Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Digital Companion Diagnostics New Entrants and Expansion Plans
Table 64. Global Digital Companion Diagnostics Revenue (USD Million) by Type (2017-2022)
Table 65. Global Digital Companion Diagnostics Revenue Share by Type (2017-2022)
Table 66. Global Digital Companion Diagnostics Revenue Forecast by Type (2023-2028)
Table 67. Global Digital Companion Diagnostics Revenue by Application (2017-2022)
Table 68. Global Digital Companion Diagnostics Revenue Forecast by Application (2023-2028)
Table 69. North America Digital Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Digital Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Digital Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Digital Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Digital Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Digital Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Digital Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Digital Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Digital Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Digital Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Digital Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Digital Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Digital Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Digital Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Digital Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Digital Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Digital Companion Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Digital Companion Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Digital Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Digital Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Digital Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Digital Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Digital Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Digital Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Digital Companion Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Digital Companion Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Digital Companion Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Digital Companion Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Digital Companion Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Digital Companion Diagnostics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Digital Companion Diagnostics Picture
Figure 2. Global Digital Companion Diagnostics Revenue Market Share by Type in 2021
Figure 3. Polymerase Chain Reaction (PCR)
Figure 4. Immunohistochemistry (IHC)
Figure 5. In Situ Hybridization (ISH)
Figure 6. Next Generation Sequencing (NGS)
Figure 7. Digital Companion Diagnostics Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Laboratories Picture
Figure 11. Other Picture
Figure 12. Global Digital Companion Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Digital Companion Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Digital Companion Diagnostics Revenue Market Share by Region (2017-2028)
Figure 15. Global Digital Companion Diagnostics Revenue Market Share by Region in 2021
Figure 16. North America Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Digital Companion Diagnostics Market Drivers
Figure 22. Digital Companion Diagnostics Market Restraints
Figure 23. Digital Companion Diagnostics Market Trends
Figure 24. Roche Holdings (Switzerland) Recent Developments and Future Plans
Figure 25. Abbott Laboratories (US) Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific (US) Recent Developments and Future Plans
Figure 27. Agilent Technologies (US) Recent Developments and Future Plans
Figure 28. Life Technologies (US) Recent Developments and Future Plans
Figure 29. GE Healthcare (UK) Recent Developments and Future Plans
Figure 30. Agendia (Angola) Recent Developments and Future Plans
Figure 31. Qiagen (Germany) Recent Developments and Future Plans
Figure 32. Genomic Health (US) Recent Developments and Future Plans
Figure 33. Myriad Genetics (US) Recent Developments and Future Plans
Figure 34. Advanced Cell Diagnostics (US) Recent Developments and Future Plans
Figure 35. Danaher (US) Recent Developments and Future Plans
Figure 36. Applied Proteomics (US) Recent Developments and Future Plans
Figure 37. Global Digital Companion Diagnostics Revenue Share by Players in 2021
Figure 38. Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Digital Companion Diagnostics Revenue Market Share in 2021
Figure 40. Global Top 10 Players Digital Companion Diagnostics Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Digital Companion Diagnostics Revenue Share by Type in 2021
Figure 43. Global Digital Companion Diagnostics Market Share Forecast by Type (2023-2028)
Figure 44. Global Digital Companion Diagnostics Revenue Share by Application in 2021
Figure 45. Global Digital Companion Diagnostics Market Share Forecast by Application (2023-2028)
Figure 46. North America Digital Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 47. North America Digital Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 48. North America Digital Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 49. United States Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Digital Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 53. Europe Digital Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 54. Europe Digital Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 55. Germany Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Digital Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Digital Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Digital Companion Diagnostics Revenue Market Share by Region (2017-2028)
Figure 63. China Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Digital Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 70. South America Digital Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 71. South America Digital Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Digital Companion Diagnostics Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Digital Companion Diagnostics Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Digital Companion Diagnostics Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Digital Companion Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source

Table of Contents

Related reports :

(Sep 22)

This report studies the global Elderly Wheelchair production, demand, key manufacturers, and key regions. This report is a detailed a...

(Sep 22)

According to our (Global Info Research) latest study, the global Elderly Wheelchair market size was valued at USD million in 2021 and is for...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential dev...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

(Sep 22)

Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, par...

Global Info Research

GLOBAL DIGITAL COMPANION DIAGNOSTICS MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy